These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29688125)

  • 1. Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior.
    Cappelletto E; Firrito C; Pizzato M; Rebuffi L; Scardi P
    Pharm Dev Technol; 2018 Dec; 23(10):1128-1135. PubMed ID: 29688125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efavirenz Dissolution Enhancement IV-Antisolvent Nanocrystallization by Sonication, Physical Stability, and Dissolution.
    Sartori GJ; Prado LD; Rocha HVA
    AAPS PharmSciTech; 2017 Nov; 18(8):3011-3020. PubMed ID: 28493004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between microstructure and bioequivalence in anti-HIV drug efavirenz.
    Fandaruff C; Segatto Silva MA; Galindo Bedor DC; de Santana DP; Rocha HV; Rebuffi L; Azanza Ricardo CL; Scardi P; Cuffini SL
    Eur J Pharm Biopharm; 2015 Apr; 91():52-8. PubMed ID: 25661587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach.
    Pawar J; Tayade A; Gangurde A; Moravkar K; Amin P
    Eur J Pharm Sci; 2016 Jun; 88():37-49. PubMed ID: 27049050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
    Lavra ZM; Pereira de Santana D; Ré MI
    Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation.
    Hoffmeister CR; Fandaruff C; da Costa MA; Cabral LM; Pitta LR; Bilatto SE; Prado LD; Corrêa DS; Tasso L; Silva MA; Rocha HV
    Eur J Pharm Sci; 2017 Mar; 99():310-317. PubMed ID: 28042101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of superdisintegrants on efavirenz release from tablet formulations.
    Rajesh YV; Balasubramaniam J; Bindu K; Sridevi R; Swetha M; Rao VU
    Acta Pharm; 2010 Jun; 60(2):185-95. PubMed ID: 21134855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation.
    Kotta S; Khan AW; Ansari SH; Sharma RK; Ali J
    Int J Pharm; 2014 Feb; 462(1-2):129-34. PubMed ID: 24374067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.
    Honório Tda S; Pinto EC; Rocha HV; Esteves VS; dos Santos TC; Castro HC; Rodrigues CR; de Sousa VP; Cabral LM
    AAPS PharmSciTech; 2013 Sep; 14(3):1244-54. PubMed ID: 23943401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
    Rao MRP; Shirsath C
    AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How tenofovir disoproxil fumarate can impact on solubility and dissolution rate of efavirenz?
    Bazzo GC; Mostafa D; França MT; Pezzini BR; Stulzer HK
    Int J Pharm; 2019 Oct; 570():118597. PubMed ID: 31401297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents.
    Ataollahi N; Broseghini M; Ferreira FF; Susana A; Pizzato M; Scardi P
    ACS Omega; 2021 May; 6(19):12647-12659. PubMed ID: 34056416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods.
    Alves LD; de La Roca Soares MF; de Albuquerque CT; da Silva ER; Vieira AC; Fontes DA; Figueirêdo CB; Soares Sobrinho JL; Rolim Neto PJ
    Carbohydr Polym; 2014 Apr; 104():166-74. PubMed ID: 24607174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
    Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
    AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid crystal suspension of Efavirenz using hot melt extrusion: Exploring the role of crystalline polyols in improving solubility and dissolution rate.
    Pawar JN; Fule RA; Maniruzzaman M; Amin PD
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():1023-1034. PubMed ID: 28575936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement.
    Taneja S; Shilpi S; Khatri K
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):978-84. PubMed ID: 25724312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
    Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
    Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biowaiver monographs for immediate release solid oral dosage forms: efavirenz.
    Cristofoletti R; Nair A; Abrahamsson B; Groot DW; Kopp S; Langguth P; Polli JE; Shah VP; Dressman JB
    J Pharm Sci; 2013 Feb; 102(2):318-29. PubMed ID: 23175470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.